The company is not selling any shares of its common stock under this prospectus and will not receive any of the proceeds from the sale of the ...

In doing so, neuro-symbolic AI stands poised to reshape how we build and integrate AI and our businesses as a whole—ushering ...

HK-listed stocks related to theme of minimally-invasive medical treatment rallied across the board this morning (14th), with ...

A digital therapeutic software company has announced a £10.35m Series A funding round, led by investor IW Capital.

Alzamend Neuro , Inc. (NASDAQ ... for an equal number of Series C Convertible Preferred Stock, along with the sale of up to 500 shares of Series C Preferred Stock and corresponding warrants ...

Q4 2024 Earnings Call Transcript March 12, 2025 Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $0.06, ...

“2024 represented the strongest financial and strategic performance in our history including more than 30% revenue growth, and a 35% reduction ...

ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...

A software company behind augmented reality glasses which support people living with neurological disorders has raised more than £10m in a Series A funding round led by IW Capital.

ClearPoint Neuro Inc (CLPT) reports a 31% revenue increase, enhanced gross margins, and strategic global expansions, despite facing operational challenges.

The marketing and supply agreement is for a period of five years for India only, to enhance distribution and in clinic presence of the two products.